Archives of Endocrinology and Metabolism (Sep 2021)

Growth hormone-releasing hormone-secreting pulmonary neuroendocrine tumor associated with pituitary hyperplasia and somatotropinoma

  • Elisa B. Lamback,
  • Daniel G. Henriques,
  • Mari C. Vazquez-Borrego,
  • Carlos H. de Azeredo Lima,
  • Leandro Kasuki,
  • Raul M. Luque,
  • Leila Chimelli,
  • Mônica R. Gadelha

DOI
https://doi.org/10.20945/2359-3997000000395
Journal volume & issue
Vol. 65, no. 5
pp. 648 – 663

Abstract

Read online

SUMMARY Acromegaly caused by ectopic growth hormone-releasing hormone (GHRH)-secreting tumor is exceedingly rare. We report a case of acromegaly secondary to GHRH secretion by an incidentally diagnosed pulmonary neuroendocrine tumor (NET) and review 47 similar cases in literature. A 22-year-old male patient presented with symptoms of pituitary apoplexy. Magnetic resonance imaging (MRI) showed apoplexy of a pituitary adenoma. Routinely prior to surgery, a chest radiography was performed which revealed a mass in the left lung. During investigation, the patient was diagnosed with metastatic GHRH-secreting pulmonary NET. In retrospect, it was noted that the patient had pituitary hyperplasia 20 months prior to the MRI which showed the presence of a pituitary adenoma. The histological findings confirmed somatotroph hyperplasia adjacent to somatotropinoma. This case suggests that GHRH secretion can be associated with pituitary hyperplasia, which may be followed by pituitary adenoma formation.